Randox launches ā¬99 Express COVID-19 Testing Service at Dublin Airport
Randox launches ā¬99 Express COVID-19 Testing Service at Dublin Airport
Randox launches €99 Express COVID-19 Testing Service at Dublin Airport
16 November 2020: Randox launches €99 Express COVID-19 Testing Service at Dublin Airport
A €99 Express COVID-19 Testing Service which launches this week in a new Travel Testing Centre at Dublin Airport, will see the creation of 50 new jobs.
The testing service from Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, utilises a robust and reliable method of testing known as PCR, which Junior Minister for Transport Hildegarde Naughton described as “the gold standard” for travel testing.
The launch of the Randox Health Travel Centre, which offers rapid next day delivery of results for pre-departure screening as well as on-arrival testing to reduce quarantine timeframes, comes just after Ireland aligned itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.
Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;
“With the introduction of the new EU traffic lights system, some people will need a COVID-19 test before travelling or equally, will want a negative test result simply for their peace of mind.
“We are delighted to have secured a location at Dublin Airport, that allows us to extend our rapid and reliable COVID-19 Testing Service, already used by a range of well-known companies, airlines and elite sporting organisations, to individual passengers and consumers.”
The Irish Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative result from a COVID-19 PCR test taken five days after arrival in Ireland.
Sophie continued;
“Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite to travel or to shorten existing quarantine periods will be a negative PCR COVID-19 test, which is currently the only method of COVID-19 testing recognised and approved by every country worldwide.
“With significant capacity in place to implement high volume PCR testing, we welcome the opportunity to bolster the travel industry’s enormous efforts to restore public confidence in international travel.
“We are committed to providing the most cost-effective and accurate test in the market to assist with the normalisation of travel, and so Randox will be opening a number of regional travel centres across Ireland over the coming weeks.”
Dublin Airport Managing Director Vincent Harrison said the health and safety of passengers and staff had been the airport’s key priority during the pandemic and that continued to be the case;
“We continue to operate a range of globally-recognised COVID-19 safety measures for the health and wellbeing of all airport visitors, and with the official opening of the Randox Health Travel Centre at Dublin Airport we can further support our passengers by offering them access to testing facilities onsite at the airport.”
The Randox €99 Express COVID-19 Testing Service is open to all asymptomatic individuals and operates from the Randox Health Travel Centre beside Terminal 2 at Dublin Airport, as well as at a testing facility in Leopardstown Dublin.
In the coming weeks Randox Health Travel Centres will also open in Galway, Limerick and Cork.
Visit booking.randox.ie to book your appointment.
For further information please email info@randoxhealth.com or phone 0800 2545 130.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
The Five Million Tests Milestone: 8th November 2020
8TH NOVEMBER: THE 5 MILLION MILESTONE
We are pleased to let you know that on Sunday 8th November, Randox surpassed 5 million tests within the UK COVID-19 National Testing Programme.
That’s an incredible 5 million samples accessioned, processed and tested by our dedicated and talented staff.
Our staff are our best asset and have risen to the challenge this pandemic has created.
They have worked hard and flexibly, been creative and innovative, and pulled together as a team to make an impact in the fight against COVID-19.
We are very proud of their efforts and teamwork.
Let us once again say thank you to each and every member of Team Randox, for the efforts they have made in 2020.
What we do at Randox remains vital to the national and global management of COVID-19 and our work is making a real and positive difference.
We continue to work hard and improve, for the sake of our family, friends and communities.
For further information please email randoxpr@randox.com
Randox in the media
Latest News
FAQs
New Express COVID-19 Testing Service with next day results launched in Dublin
New Express COVID-19 Testing Service with next day results launched in Dublin
06 November 2020: New Express COVID-19 Testing Service with next day results launched in Dublin
A new express COVID-19 testing service has now launched in Ireland, with a rapid next day delivery of results.
From global diagnostics provider Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, the service utilises a robust and reliable method of testing known as PCR, the only method recognized and approved for travel testing.
The PCR testing, which Junior Minister for Transport Transport Hildegarde Naughton described as “the gold standard,” is available in Dublin for pre-travel clearance, or simply for those wanting a COVID-19 test for peace of mind.
Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;
“We appreciate that many people will want a COVID-19 test before travelling home this Christmas, or equally, will want a negative test result to reduce quarantine times and enable them to spend more time with loved ones.
“PCR testing is currently the only method of COVID-19 testing which is recognised by every country worldwide. Our rapid, accurate and reliable testing service, used already by a range of well-known companies, airlines and elite sporting organisations, will help get plans off to a hassle-free start for travellers and non-travellers alike.”
The launch of the Randox testing service comes just as Ireland aligns itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.
The Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative test result from a COVID-19 test taken five days after arrival in Ireland.
Sophie continued;
“Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite will be a negative PCR COVID-19 test prior to travel or to shorten quarantine periods.
“We have significant capacity in place to implement high volume testing and with our PCR testing service, we look forward to supporting the travel industry’s enormous efforts to restore public confidence in international travel.”
The Randox Express COVID-19 Testing Service is priced at €99, is open to all asymptomatic individuals and operates from the Clayton Hotel in Dublin.
Visit booking.randox.ie to book your appointment.
For further information please email info@randoxhealth.com or phone 0800 2545 130.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
India Must Stop Misusing Antibiotics in Dairy Sector, According to CSE Report
India Must Stop Misusing Antibiotics in Dairy Sector, According to CSE Report
The Centre for Science and Environment (CSE) has raised concerns over whether the milk we consume is safe. Hosting a virtual meeting in July, the CSE discussed the use of antibiotics with the world’s largest producer of milk, India. Over 188 million tonnes of milk was produced by India over the period of 2018-2019 and lead with 22% of global milk production.
A recent assessment by the CSE has found indication of antibiotic abuse in milk producing cattle.
“We have found that antibiotics are extensively misused in the dairy sector; antibiotic residues remain largely untested in milk, an integral part of Indian diets, particularly of children,” said CSE Director General Sunita Narain. “While we continue to struggle against COVID-19, we are staring at another pandemic like situation – that of antibiotic resistance fueled by the way we are producing our food, which has become chemical-intensive.”
Antibiotics such as penicillin, aminoglycosides and fluroquinolones are being ‘indiscriminately’ used by dairy farmers according to the CSE. These antibiotics are among the most important in human health. The World Health Organisation (WHO) has warned as we face growing concerns over an antibiotic resistance, such antibiotics should be preserved.
Despite laws stating that antibiotics should only be prescribed and administered by a registered veterinarian, the CSE said that some farmers are illegally attaining and injecting animals themselves without the supervision of veterinarians.
“Farmers often sell milk while the animal is under treatment, which increases the chances of antibiotic residues in the milk,” explained Amit Khurana, the CSE’s Food Safety and Toxins Programme Director. “While milk sold directly to consumers is not tested, contrary to what one would expect, processed milk sold in packets is also largely unchecked for antibiotic residues.
“This explains why, despite pooling and processing, packed milk samples from several states had antibiotic residues in the FSSAI’s [Food Safety and Standards Authority of India] milk quality survey of 2018.”
However, CSE noted the virtual meeting has encouraged positive signs of action in the diary industry in India.
“The issues highlighted by the CSE assessment have been well recognised by the experts and stakeholders. These experts have also recommended several measures for minimising antibiotic misuse in the Indian dairy sector.”
In order to minimise the threat of antibiotic resistance, the CSE have recommended “preventative measures” such as;
- Routine observation of drugs residues in milk
- Modifying the existing standards for antibiotic residues in milk
- Limiting misuse of essential antibiotics such as penicillin
Such measures, Khurana noted, are showing some success. “Information shared by various organisations, agencies and experts suggest that ethno-veterinary medicines, better management of sub-clinical mastitis, and good farm management are contributing towards reducing antibiotic misuse.”
“India is now talking about antibiotic resistance in the one-health perspective,” noted Narain. “There is a shared concern, and all voices are now together in expressing that concern.” As such he believes further (and necessary) action will be taken.
“We must ramp up surveillance and testing, put a complete stop to the use of critically important antibiotics and penalise their use,” he added, “and work with farmers and the agriculture-dairy sectors to innovate on solutions.”
Randox Food Diagnostics
Randox Food Diagnostics recognise the pressure the dairy industry is under to mass produce high quality products whilst complying with regulations and have developed the solution. A comprehensive range of easy to use, accurate milk analysis methods for the qualitative and quantitative detection of contaminants in milk.
With 6 Biochip arrays available including the revolutionary InfiniPlex for Milk, Randox Food provide the highest quality testing platforms for the screening of antimicrobials and are the only commercial supplier of a multiplexing anthelmintics array in milk.
Biochip Array Technology saves time and money whilst enabling users to get a deeper insight into milk quality and ensure a safe supply chain.
Contact us at info@randoxfooddiagnostics.com, or visit https://www.randoxfood.com/milk-analysis/ to find out more about our milk testing solutions.
Want to know more?
Contact us or visit our Randox Food Diagnostics website.
Related Products
Meat & Seafood
Milk
Honey
Wine
Official comment on extension of COVID-19 testing contract
OFFICIAL RANDOX STATEMENT: EXTENSION OF COVID-19 TESTING CONTRACT
Acknowledging the extension of Randox’s contract to provide COVID-19 testing within Pillar 2 of the UK’s National Testing Programme, Randox Founder and Managing Director Dr Peter FitzGerald said;
“We take very seriously our responsibility to ensure that vital laboratory testing for Covid-19 continues and expands during the winter months.
“We have extensively ramped up our capacity and made significant private investment in order to fulfil and exceed our commitment to the National Testing Programme. All at Randox are fully committed to supporting the programme, and we look forward to continuing to play our role, which is crucial to the economic and social wellbeing of the nation.”
Press enquiries should be emailed to randox@newcenturymedia.co.uk
Randox in the media
Latest News
FAQs
Whole pathogen multiplex controls to support testing for cold, cough and COVID
27 October 2020
Whole pathogen multiplex controls to support testing for cold, cough and COVID
Just in time for flu season, global diagnostics company Randox Laboratories has unveiled a range of whole pathogen multiplex controls that cover multiple viral and bacterial pathogens which cause respiratory disease.
Inclusive of SARS-CoV-2, Influenza A & B, and Respiratory Syncytial Virus (RSV), the Qnostics Multiplex Respiratory Pathogen Controls (RTX) facilitate diagnosis of the likes of cold and flu, and importantly, the differentiation of these respiratory diseases from COVID-19.
Using a control line that covers a range of respiratory pathogens in this way will allow laboratories to streamline their testing, consolidate QC, and ultimately save time, money and resource.
Lynsey Adams, Randox Quality Control Manager, explained;
“When the use of time and resources are critical such as in COVID-19 testing, the use of highly characterised controls enables laboratories to meet their daily QC needs and accreditation requirements.
“Accurate and reliable laboratory testing is an essential aspect of the management of COVID-19 and other respiratory diseases, so we are pleased to be able to offer these new controls which will crucially support the validation, verification and performance monitoring of molecular respiratory assays.”
The new RTX controls, which are whole pathogen for compatibility with the majority of commercial and in-house assays, are used to monitor the full testing process, from extraction to amplification and detection.
The Multiplex Respiratory Controls will support public health testing strategies during the incoming flu season and are suited for the test menus of most syndromic assays.
Lynsey continued;
“The Randox Qnostics Multiplex Respiratory Pathogen Controls are clinically relevant for full-process validation. Liquid frozen for user convenience and ease of use, the development of the controls using whole pathogen material ensures clinical relevance from extraction to amplification and detection.”
Randox Qnostics Multiplex Respiratory Pathogen Controls are manufactured to ISO 13485 standards and are in line with ISO 15189:2012 regulatory requirements.
Key Features and Benefits of the new RTX Controls:
- Whole pathogen controls – the controls contain the entire genome meaning they are compatible with the majority of commercial and in-house assays.
- Full process control – whole pathogen controls are the ideal material for full-process validation, monitoring the testing process from extraction to amplification and detection, to ensure ultimate quality assurance in laboratories.
- Highly characterised – Qnostics controls are quantified by digital PCR to ensure batch to batch reproducibility and are traceable to an internal reference preparation, to ensure metrological traceability of test results obtained by different diagnostic workflows.
- True Third Party – An independent, unbiased assessment of assay performance is ensured in line with ISO 15189:2012 regulatory requirements.
- Superior Manufacturing – Qnostics controls are manufactured under ISO 13485 guidelines to ensure quality and traceability.
- Liquid for Ease-of-Use – the controls are conveniently supplied in a liquid frozen format meaning there is no additional preparation or handling required.
For more information visit https://www.randox.com/molecular-infectious-disease-controls/respiratory-infection-testing/
For further enquiries please email marketing@randox.com
QNOSTICS
QCMD
CORONAVIRUS
U.S. Drug Overdose Deaths Resurge to Record During the Pandemic
22 October 2020: U.S. Drug Overdose Deaths Resurge to Record During the Pandemic
Drug overdose deaths in the USA rose to a record high in 2019, after falling for the first time for 25 years in 2018. Almost 72,000 people died from drug overdoses in 2019 according to the preliminary data that was released by the Centres for Disease Control and Prevention earlier this year.
Though there is currently no hard data available, there is speculation that the pandemic is complicating and worsening the surge, as 2020 looks to be even more devastating than 2019. Data collected by The New York Times saw for the first half of 2020 drug overdose deaths have risen by an average of 13 percent across America compared to last year. If this trend continues into the rest of the year, it will be the sharpest rise in annual drug deaths since 2016, when fentanyl made its way into US drug trafficking and street supply.
Increased funding toward addiction treatment, prevision and recovery services did shows signs of improving overdose deaths. Though the government has made this positive headway in the last few years in how they tackle the drug epidemic in America, this progress could be threatened by the current COVID-19 pandemic.
Earlier in the month, Brett Giroir, the administration’s assistant secretary for health, said in a statement, “We understand that there is an extraordinary amount of work to do, especially now as we are also dealing with the Covid-19 pandemic that could markedly affect our nation’s mental health and risk of substance use.”
Several public health experts said conditions created by the pandemic could hurt the nation’s fragile progress in fighting the surge of drug deaths but noted that the overdose rate was on its way back up well before the virus arrived. “Covid just makes it a bit worse,” said Dr. Dan Ciccarone, a professor of medicine at the University of California, San Francisco, who studies the opioid epidemic. “It’s a small wave riding on top of a tsunami that continues to devastate.”
Although official statistics on 2020 overdose deaths won’t be available for a long time, there is local evidence showing drug related deaths are rising into 2020.
Increase in Drug related deaths from 2019 through the first portion of 2020
Though a lot of this data precedes the coronavirus pandemic, researchers believe there are several reasons why the virus could worsen the trend.
When state lockdowns first began in March, Dr. Anna Lembke, a clinician with Stanford’s Addiction Medicine Dual Diagnosis Clinic, noticed many of her patients showing signs of improving. “Many patients described a kind of peacefulness without the constant hubbub of modern life and the constant triggers they’re exposed to,” she said.
However, in response to the virus, the US government has done something unheard-of: it relaxed rules and regulations around prescribing methadone and buprenorphine, two commonly prescribed opioid addiction treatments. Patients no longer needed to attend daily in person appointments to receive their methadone prescriptions and could instead be given 4 weeks’ worth at a time. Doctors no longer need to meet in person to prescribe buprenorphine.
This was initially celebrated as a positive change, however as the pandemic has progressed and people have remained isolated, lockdown has become harmful to people with mental health issues and drug addiction disorders.
“Social isolation has always been a huge component of drug overdose risk,” said Traci Green, an epidemiologist at Brown University who studies drug abuse and addiction. “So much of what we’ve been trying to do has been completely unravelled.”
Experts have pointed to other dangers lockdown poses such as;
- Lack of revival fall back from other users due to an increase in solo drug users
- Less emotional support as in person visits are scaled back
- Inconsistent drug strength and quality
- Supply or income disruption leading to inconsistent drug use habits and accidental overdose
Randox Toxicology
Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in hospitals and medical centres, as pressure increases with the rising number of drug overdose deaths in the US.
Randox Toxicology Products and Services
BIOCHIP
EVIDENCE
ELISA
MATRICES
Want to know more about Randox?
Contact us or visit our homepage to view more.
RTS Blog: Use of Reporting Services in Medico-Legal Cases
19 October 2020: Use of Reporting Services in Medico-Legal Cases
At Randox Testing Services we provide several reporting options that are available for use should they be required in medico-legal cases, including expert witness reports and medical reviews to add clarity and expert examination to results.
Why is Drug and Alcohol Testing in Medico-legal Cases Important?
Drug and alcohol testing is important to ensure child protection from the detrimental effects of parental substance misuse and to ensure they have a quality of life they deserve. In addition, it is also important to enable parents the opportunity to get the help and support they need and begin rehabilitation treatment.
Doing the right thing by the child is the main priority, and where possible parent and child relationships are sought to be maintained. Drug and alcohol testing assists in these efforts and in such cases abstinence monitoring testing may be required to assess a parent’s recovery e.g. if a visitation case is being reassessed.
Expert Witness Services
An Expert Witness Report is an interpretation of the results of a drug or alcohol test. It provides a detailed explanation of whether substances tested for were detected as well as information regarding chain of custody compliance and testing procedures.
As trusted industry experts Randox Testing Services staff are trained to act as Expert Witnesses in legal cases involving drug and alcohol testing. Our experienced team of Reporting Scientists have undergone extensive Expert Witness training to provide professional witness statements or fully written reports for use as evidence in a court of law or industrial tribunals.
Where required a Senior Toxicologist from Randox Testing Services can attend legal proceedings in person to provide expert witness testimony.
Medical Review Officer
Our medical review service offers independent and expert examination of positive results under medical confidentiality.
A positive result from a drug and alcohol analysis is a cause for concern. However, there are some cases when there is a legitimate medical reason for the result. Our medical review service allows for the independent and confidential review of the result to determine the cause of a positive result, for example, if an employee is taking prescription medication.
The Medical Review Officer (MRO) assesses a positive result in the light of the donor’s medical background to determine if there is a legitimate medical reason for the result. The MRO helps protect both the rights of the employee being tested and the employer requiring the testing.
Randox Testing Services
At Randox Testing Services we offer customers access to our expertise through providing various reporting options to customers. These reporting services can be utilised in cases where extra clarity or examination is needed to investigate the outcome of a drugs test. These reports are utilised by workplaces as well as those operating within the medico-legal sector.
For more information on our training, education and reporting services, visit https://www.randoxtestingservices.com/workplace-drug-and-alcohol-testing/training-education-reporting-and-policy/
If you would like to find out more about our drug and alcohol testing programs, contact us today to speak to one of our experience business development executives.
Email: testingservices@randox.com
Phone: 028 9592 2801
Want to know more?
Contact us or visit our website to read more.
Randox delves into the inner workings of a racing driverās body and mind for first-ever Goodwood SpeedWeek
13 October 2020
Randox delves into the inner workings of a racing driver’s body and mind for first-ever Goodwood SpeedWeek
Goodwood SpeedWeek will bring fans closer to the action than ever before with a one-off digital technology playground that viewers can experience from the comfort of their own homes – and Randox will feature as part of the event with a documentary showing the inner workings and hidden brilliance of a racing driver’s mind and body under stress.
Being shown on Saturday 17 October, ‘The Racing Mind’ documentary looks at the psychological, physiological and chemical make up of racing drivers.
Millions of spectators will be able to enjoy 360-degree audio-visual displays, take a virtual paddock tour, use chatroom functionality to question their favourite drivers, and interact with the action through quizzes, polls, competitions and a ‘podium predictor’.
Goodwood Speedweek, which runs from 16-18 October 2020, is the most ambitious event to ever take place at the Goodwood Motor Circuit with more than 12 miles of high-speed fibre cabling being laid and 49 high-definition cameras installed, including 19 trackside cameras and 15 live on-boards. A television crew of 180 operators will help bring the action to life with 10 presenters and two TV studios required to cover all the action.
Each day will be dedicated to celebrating the automotive industry’s past, present and future – bringing together the best elements of the Festival of Speed and Revival using the latest technology.
This will be reflected in the iconic Goodwood Shootout presented by Mastercard on Sunday 18 October, with a winner-takes-all one-lap competition between some of the fastest machines in motorsport across the years, including hypercars, single-seaters and prototype sports cars.
The Duke of Richmond said;
“Technology is a core feature of Goodwood motorsport events and we strive to showcase the most innovative and forward-thinking mobility innovations. At Goodwood SpeedWeek we were presented with a unique opportunity to go one step further, quite literally placing digital right at the heart of the experience. It’s allowed us to raise the bar even higher, offering a once in a lifetime, interactive experience that is accessible to viewers anywhere in the world.”
The Racing Mind (Saturday 17th October)
In partnership with Randox, Goodwood Speedweek will show viewers the inner workings and hidden brilliance of a racing driver’s mind and body under stress.
The Technology Showcase (Sunday 18th October)
- The first autonomous lap: Einride will undertake an autonomous lap on the Goodwood Motor Circuit including a behind-the-scenes look at how it was achieved.
- F1 Technology: Before taking to the track to celebrate 70 years of F1, there will be a live grid walk of cars charting the evolution of technology in F1 through the ages.
- Car vs Bike vs Drone: An all-electric race between the Virgin Formula E, Electric Harley and Drone racer on the Driftkhana course.
- Jet Suit: A look behind-the-scenes of Gravity and how you train to become a jet suit pilot, followed by a unique race between three jet racers.
- Ford Electric Mustang: The all-electric Mach-E Mustang 1400 prototype will take to the track for a drift demonstration.
- Sennheiser: An interactive demonstration of 360-degree binaural audio, live from the heart of the event.
Fans can sign up for alerts at: https://www.goodwood.com/motorsport/goodwood-speedweek/
As well as streaming options through goodwood.com and social media, SpeedWeek will be broadcast live on ITV1 and ITV4 during the event;
- Friday 16th Oct – 16:30-18:30 (ITV4)
- Saturday 17th Oct – 14:00-16:00 (ITV4)
- Sunday 18th Oct – 14:00-16:00 (ITV1)
A selection of highlight programmes the week after the event on ITV4;
- First Glance – Wednesday 21st Oct – 21:30
- Highlights 1 – Thursday 22nd Oct – 20:00
- Highlights 2 – Thursday 22nd Oct – 21:00
Stay up to date with all future announcements and on-event action with the official hashtag #gwspeedweek across Goodwood social channels:
- @GoodwoodRRC (Twitter)
- Goodwood Road & Racing (Facebook)
- @goodwoodrrc (Instagram)
Want to know more?
Contact us or visit our Randox Health page to view more.
Our Randox Health programmes
Everyman
Everywoman
Signature
Specialised testing
EU Traffic Light System: How to get a COVID-19 PCR test before travelling
12 October 2020
EU Traffic Light System: How to get a COVID-19 PCR test before travelling
EU Traffic Light System: How to get a COVID-19 PCR test before travelling
As Covid-19 infection rates continue to rise in many parts of the world, an increasing number of countries are asking for a negative PCR test as a means of proof that travellers do not have the Covid-19 virus.
Whilst not yet a common requirement globally, it is understood that the EU could soon be turning to a Traffic Light System that will require pre-departure testing for individuals departing any of the 15 ‘red list’ countries – which includes the UK and could be extended to include Ireland.
Whilst there are currently a number of countries across the EU that do not require a negative COVID test for visitors from the UK, the implementation of this co-ordinated approach across the EU will place common requirements on all travellers from the UK, no matter which country they are visiting.
It could also be used in support of reduced quarantine in those countries which require it.
So – what is a PCR test?
PCR stands for Polymerase Chain Reaction and is a method of testing used to detect infectious disease, including COVID-19.
A PCR test is performed in a laboratory and is indicative of an individual’s COVID status at the time their sample is taken. It does not show previous infection.
Where can I get a COVID PCR test done?
PCR tests are available at Randox Health via an in-clinic appointment, or a home sample collection.
Are home tests accepted as proof of my COVID status?
It is important to note that many countries do not accept ‘home tests’ as proof of a negative COVID-19 result. Results must show that the test was performed in a certified laboratory.
Whilst Randox Health offers a home sample collection kit, all our testing is performed using PCR methods in our certified laboratories.
If the country you are travelling to requires a PCR test result, we’ve got you covered.
How do I know if I need a COVID PCR test?
You can check the entry requirements for your destination at gov.uk/foreign-travel-advice
Requirements are subject to change, so keep checking in the weeks and days leading up to your trip.
When do I take my sample for testing?
Your destination country will determine the time frame required for testing. For example, it may state that your sample needs to be taken and tested within 72 hours before departure / arrival. You cannot be swabbed before this time.
It is best to book / order your test in advance and take it as early as possible within your window, so that you allow for the maximum amount of time to get your test results back.
How long do I wait for my results?
Upon receipt of sample at Randox’s laboratories, you will receive your results within 24 hours.
Our rapid, accurate and reliable COVID-19 testing service will help get your trip off to a hassle-free start, with minimum disruption to your travel plans.
Visit https://www.randoxhealth.com/covid-travel-certificate/ to order your home sample collection kit or book your clinic appointment.
For further information please email info@randoxhealth.com or phone 0800 2545 130.
Want to know more about Randox?
Contact us or visit our homepage to view more.